(Q43656932)

25 November 2017

title

Comparative effects of dextromethorphan and dextrorphan on morphine, methamphetamine, and nicotine self-administration in rats (English)

1 reference

25 November 2017

0 references

1 reference

Glick SD

1

1 reference

25 November 2017

Maisonneuve IM

series ordinal

2

1 reference

25 November 2017

Dickinson HA

series ordinal

3

1 reference

25 November 2017

Kitchen BA

series ordinal

4

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

European Journal of Pharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

422

1 reference

25 November 2017

issue

1-3

1 reference

25 November 2017

page(s)

87-90

1 reference

Dextromethorphan and dextrorphan in rats: common antitussives--different behavioural profiles.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

Dextromethorphan for treatment of complex partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

18-MC reduces methamphetamine and nicotine self-administration in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

Discriminative stimulus effects of dextromethorphan in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

Dextromethorphan alters methamphetamine self-administration in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

N-methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: a pilot study with dextromethorphan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

Safety and tolerance of oral dextromethorphan in patients at risk for brain ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

Dextromethorphan reduces intravenous cocaine self-administration in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

Induction of phencyclidine-like behavior in rats by dextrorphan but not dextromethorphan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901066-4

10.1016/S0014-2999(01)01066-4

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference